Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA requires BSX to include stent "shrinkage" risk in Promus Element label
FDA requires BSX to include stent "shrinkage" risk in Promus Element label
FDA requires BSX to include stent "shrinkage" risk in Promus Element label
Submitted by
admin
on December 19, 2011 - 6:27pm
Source:
Mass Device
News Tags:
FDA
Boston Scientific
Promus Element
stents
Headline:
FDA requires BSX to include stent "shrinkage" risk in Promus Element label
Do Not Allow Advertisers to Use My Personal information
